Pute Biomedical

Shenzhen Pute Biomedical Engineering Co., Ltd. was established in 2006 and is a national high-tech enterprise integrating R&D, production, and sales. Since its establishment, with the goal of introducing advanced domestic and foreign technologies, acting as an agent for outstanding foreign brand products, and developing products with independent intellectual property rights, it has mainly devoted itself to the domestic and international blood technology field, providing high-quality industry solutions and product technical services.
After fourteen years of development, we have established a biotechnology platform that is sustainable and poised for rapid growth. Now, we are creating another new development platform, grounded in the coming era of big health. We are now beginning to build a health platform that can serve the entire society in the future—the Blood Destiny Technology Platform.
The Blood Destiny Technology Platform was established in 2017 and is a B2C Internet+ service platform under Pute Medical. It is not a hardware project. The project mainly works with government blood stations to serve voluntary blood donors, covering the entire blood donation process management and services (online and offline). Based on different actual situations and specific functional requirements, the service platform can provide customized services. Its APP, mini-programs, and official accounts are all in operation; APP: Blood Destiny; official accounts: Loving Heart Points, Blood Destiny Public Welfare Foundation, etc., 16 in total. It officially began operations in March 2019, serving 15 million voluntary blood donors nationwide.
For more details, please visit our company's official website.